Ariel Weinstein is a seasoned executive with extensive experience in the healthcare and medical technology sectors. Currently serving as Chief Executive Officer at Nervio since May 2023, Ariel is dedicated to simplifying intraoperative neuromonitoring through AI signal analysis. As CEO of Ophthalmic Sciences since August 2020, Ariel has pioneered non-contact visual intraocular pressure measurement, significantly benefiting glaucoma patients. Previous roles include CEO of OCON Healthcare, leading the development of innovative women's health implants from concept to market, and various leadership and operational roles at companies such as Intramed Systems and Orthoaxis Ltd., where Ariel focused on groundbreaking medical devices. Ariel's educational background includes a Master of Science in Management from New York University and a Bachelor of Emergency Medical Services from Ben-Gurion University of the Negev.
This person is not in any teams
This person is not in any offices